Biogen is Planning to Launch a First Trial, Testing Spinraza in Children Previously Given Zolgensma
Jul 31, 2020, 12:00 AM
SMA News Today’s multimedia associate, Price Wooldridge, discusses the news Biogen is planning to launch a first trial, testing Spinraza in children previously given Zolgensma.
Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/